Outcomes of stereotactic radiotherapy for a new clinical stage i lung cancer arising postpneumonectomy

Cancer

Volumn 115, Issue 3, 2009, Pages 587-594

  Haasbeek, Cornells J A ^a   Lagerwaard, Frank J ^a   De Jaeger, Katrien ^b   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

Lung cancer; Postpneumonectomy; Second primary; Stereotactic radiotherapy

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; LUNG RESECTION; OXYGEN THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SAFETY; SECOND CANCER; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; NEOPLASMS, SECOND PRIMARY; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONECTOMY; RADIOSURGERY; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 60049100488     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24068     Document Type: Article

References (39)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-543.
2. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006; 81:1013-1019.
3. Birim O, Kappetein AP, Goorden T, van Klaveren RJ, Bogers AJ. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg. 2005;80:1021-1026.
4. Daniels JM, Eerenberg JP, Rijna H, et al. Mitotic index does not predict prognosis in stage IA non-small cell lung cancer. Lung Cancer. 2002;38:163-167.
5. Ali MK, Ewer MS, Atallah MR, et al. Regional and overall pulmonary function changes in lung cancer. Correlations with tumor stage, extent of pulmonary resection, and patient survival. J Thorac Cardiovasc Surg. 1983;86:1-8.
6. Nakahara K, Monden Y, Ohno K, Miyoshi S, Maeda H, Kawashima Y. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg. 1985;39:260-265.
7. Win T, Groves AM, Ritchie AJ, Wells FC, Cafferty F, Laroche CM. The effect of lung resection on pulmonary function and exercise capacity in lung cancer patients. Respir Care. 2007;52:720-726.
8. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120-129.
9. Pasini F, Verlato G, Durante E, et al. Persistent excess mortality from lung cancer in patients with stage I non- small-cell lung cancer, disease-free after 5 years. Br J Cancer. 2003;88:1666-1668.
10. Haasbeek CJ, Senan S, Smit EF, Paul MA, Slotman BJ, Lagerwaard FJ. Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. Oncologist. 2008;13:309-319.
11. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685-692.
12. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non- small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:S94-S100.
13. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2004;60:1026-1032.
14. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427-1431.
15. Onishi H, Araki T, Shirato H, et al. Stereotactic hypo-fractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623-1631.
16. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787-795.
17. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010-1015.
18. Lagerwaard FJ, Voet PW, van Meerbeeck JP, Burgers SA, Senan S. Curative radiotherapy for a second primary lung cancer arising after pneumonectomy - techniques and results. Radiother Oncol. 2002;62:21-25.
19. Ohashi T, Takeda A, Shigematsu N, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys. 2005;62:1003-1008.
20. Lagerwaard FJ, van der Geld Y, Slotman BJ, Senan S. Quality of life after stereotactic radiotherapy for medically inoperable stage I lung cancer. Int J Radiat Oncol Biol Phys. 2006;66S133-S134.
21. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002; 359:1388-1393.
22. Herder GJ, Kramer H, Hoekstra OS, et al. Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol. 2006;24:1800-1806.
23. Fowler JF, Tome WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys. 2004;60:1241-1256.
24. Spaggiari L, Grunenwald D, Girard P, Baldeyrou P. Completion right lower lobectomy for recurrence after left pneumonectomy for metastases. Eur J Cardiothorac Surg. 1997;12:798-800.
25. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995; 60:615-622.
26. Seppenwoolde Y, Lebesque JV, de Jaeger K, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys. 2003;55:724-735.
27. Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology. 2003;229:475-481.
28. Cox JE, Chiles C, McManus CM, Aquino SL, Choplin RH. Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology. 1999;212:165-168.
29. Laurent F, Michel P, Latrabe V, Tunon de Lara M, Marthan R. Pneumothoraces and chest tube placement after CT-guided transthoracic lung biopsy using a coaxial technique: incidence and risk factors. AJR Am J Roentgenol. 1999;172:1049-1053.
30. Topal U, Ediz B. Transthoracic needle biopsy: factors effecting risk of pneumothorax. Eur J Radiol. 2003;48:263-267.
31. Covey AM, Gandhi R, Brody LA, Getrajdman G, Thaler HT, Brown KT. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol. 2004;15:479-483.
32. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med. 2007;13:361-366.
33. Rubins J, Unger M, Colice GL. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP Evidence-based Clinical Practice Guideline (2nd edition). Chest. 2007;132:355S-367S.
34. Kittle CF, Faber LP, Jensik RJ, Warren WH. Pulmonary resection in patients after pneumonectomy. Ann Thorac Surg. 1985;40:294-299.
35. Levasseur P, Regnard JF, Icard P, Dartevelle P. Cancer surgery on a single residual lung. Eur J Cardiothorac Surg. 1992;6:639-640.
36. Westermann CJ, van Swieten HA, Brutel de la Riviere A, van den Bosch JM, Duurkens VA. Pulmonary resection after pneumonectomy in patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1993;106:868-874.
37. Spaggiari L, Grunenwald D, Girard P, et al. Cancer resection on the residual lung after pneumonectomy for bronchogenic carcinoma. Ann Thorac Surg. 1996;62:1598-1602.
38. Donington JS, Miller DL, Rowland CC, et al. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002;74:154-158.
39. Terzi A, Lonardoni A, Scanagatta P, Pergher S, Bonadiman C, Calabro F. Lung resection for bronchogenic carcinoma after pneumonectomy: a safe and worthwhile procedure. Eur J Cardiothorac Surg. 2004;25:456-459.